These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 24159176)
21. Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia. Johansson P; Bergmann A; Rahmann S; Wohlers I; Scholtysik R; Przekopowitz M; Seifert M; Tschurtschenthaler G; Webersinke G; Jäger U; Siebert R; Klein-Hitpass L; Dührsen U; Dürig J; Küppers R Int J Cancer; 2016 Jan; 138(1):121-4. PubMed ID: 26199174 [TBL] [Abstract][Full Text] [Related]
22. Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma. Schumacher MA; Schmitz R; Brune V; Tiacci E; Döring C; Hansmann ML; Siebert R; Küppers R Haematologica; 2010 Jan; 95(1):153-7. PubMed ID: 19648161 [TBL] [Abstract][Full Text] [Related]
23. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Zhou Q; Wang H; Schwartz DM; Stoffels M; Park YH; Zhang Y; Yang D; Demirkaya E; Takeuchi M; Tsai WL; Lyons JJ; Yu X; Ouyang C; Chen C; Chin DT; Zaal K; Chandrasekharappa SC; Hanson EP; Yu Z; Mullikin JC; Hasni SA; Wertz IE; Ombrello AK; Stone DL; Hoffmann P; Jones A; Barham BK; Leavis HL; van Royen-Kerkof A; Sibley C; Batu ED; Gül A; Siegel RM; Boehm M; Milner JD; Ozen S; Gadina M; Chae J; Laxer RM; Kastner DL; Aksentijevich I Nat Genet; 2016 Jan; 48(1):67-73. PubMed ID: 26642243 [TBL] [Abstract][Full Text] [Related]
24. Functional effect of polymorphisms in the promoter of TNFAIP3 (A20) in acute pancreatitis in the Han Chinese population. Liu Y; Dan G; Wu L; Chen G; Wu A; Zeng P; Xu W PLoS One; 2014; 9(7):e103104. PubMed ID: 25050625 [TBL] [Abstract][Full Text] [Related]
25. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity. Koumakis E; Giraud M; Dieudé P; Cohignac V; Cuomo G; Airò P; Hachulla E; Matucci-Cerinic M; Diot E; Caramaschi P; Mouthon L; Riccieri V; Cracowski JL; Tiev KP; Francès C; Amoura Z; Sibilia J; Cosnes A; Carpentier P; Valentini G; Manetti M; Guiducci S; Meyer O; Kahan A; Boileau C; Chiocchia G; Allanore Y Arthritis Rheum; 2012 Aug; 64(8):2746-52. PubMed ID: 22488580 [TBL] [Abstract][Full Text] [Related]
26. Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome highlight T cell-initiated autoimmunity. Wang Y; Chen S; Chen J; Xie X; Gao S; Zhang C; Zhou S; Wang J; Mai R; Lin Q; Lin J; Matucci-Cerinic M; Zhang G; Furst DE Ann Rheum Dis; 2020 Feb; 79(2):268-275. PubMed ID: 31848144 [TBL] [Abstract][Full Text] [Related]
27. Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren's syndrome patients: case series study and review of the literature. Gorodetskiy VR; Probatova NA; Radenska-Lopovok SG; Ryzhikova NV; Sidorova YV; Sudarikov AB Rheumatol Int; 2020 Mar; 40(3):499-506. PubMed ID: 31707561 [TBL] [Abstract][Full Text] [Related]
28. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP. Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH Oncotarget; 2017 Mar; 8(10):17038-17049. PubMed ID: 28152507 [TBL] [Abstract][Full Text] [Related]
29. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management. Nocturne G; Mariette X Br J Haematol; 2015 Feb; 168(3):317-27. PubMed ID: 25316606 [TBL] [Abstract][Full Text] [Related]
30. Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis. Wang X; Zhu L; Liao Z; Zhang F; Xu L; Xu Y; Chen S; Yang L; Zhou Y; Li Y J Immunol Res; 2014; 2014():492872. PubMed ID: 24971370 [TBL] [Abstract][Full Text] [Related]
31. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases. Mele A; Cervantes JR; Chien V; Friedman D; Ferran C Adv Exp Med Biol; 2014; 809():163-83. PubMed ID: 25302371 [TBL] [Abstract][Full Text] [Related]
32. MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndrome. Fragkioudaki S; Nezos A; Souliotis VL; Chatziandreou I; Saetta AA; Drakoulis N; Tzioufas AG; Voulgarelis M; Sfikakis PP; Koutsilieris M; Crow MK; Moutsopoulos HM; Mavragani CP Sci Rep; 2017 Aug; 7(1):7354. PubMed ID: 28779180 [TBL] [Abstract][Full Text] [Related]
33. TREX1 variants in Sjogren's syndrome related lymphomagenesis. Nezos A; Makri P; Gandolfo S; De Vita S; Voulgarelis M; Crow MK; Mavragani CP Cytokine; 2020 Aug; 132():154781. PubMed ID: 31326279 [TBL] [Abstract][Full Text] [Related]
34. Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas. Zhu D; Ikpatt OF; Dubovy SR; Lossos C; Natkunam Y; Chapman-Fredricks JR; Fan YS; Lossos IS Am J Hematol; 2013 Sep; 88(9):730-5. PubMed ID: 23720088 [TBL] [Abstract][Full Text] [Related]
35. The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study. De Vita S; Gandolfo S; Zandonella Callegher S; Zabotti A; Quartuccio L Clin Exp Rheumatol; 2018; 36 Suppl 112(3):150-156. PubMed ID: 30156548 [TBL] [Abstract][Full Text] [Related]
36. Genetic associations to germinal centre formation in primary Sjogren's syndrome. Reksten TR; Johnsen SJ; Jonsson MV; Omdal R; Brun JG; Theander E; Eriksson P; Wahren-Herlenius M; Jonsson R; Nordmark G Ann Rheum Dis; 2014 Jun; 73(6):1253-8. PubMed ID: 23606706 [TBL] [Abstract][Full Text] [Related]
37. Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma. Bu R; Bavi P; Abubaker J; Jehan Z; Al-Haqawi W; Ajarim D; Al-Dayel F; Uddin S; Al-Kuraya KS Leuk Lymphoma; 2012 Oct; 53(10):1971-7. PubMed ID: 22397314 [TBL] [Abstract][Full Text] [Related]
38. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Honma K; Tsuzuki S; Nakagawa M; Tagawa H; Nakamura S; Morishima Y; Seto M Blood; 2009 Sep; 114(12):2467-75. PubMed ID: 19608751 [TBL] [Abstract][Full Text] [Related]
39. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia. Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343 [TBL] [Abstract][Full Text] [Related]
40. Thyroid disease in Sjögren's syndrome. Jara LJ; Navarro C; Brito-Zerón Mdel P; García-Carrasco M; Escárcega RO; Ramos-Casals M Clin Rheumatol; 2007 Oct; 26(10):1601-6. PubMed ID: 17558463 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]